We found 3 drugmaker programs for Neuroendocrine Tumors medicines. Tell us your insurance below and we'll show what to try first.
Help for Neuroendocrine Tumors depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
People with private insurance may pay as little as $0 for Lutathera. The co-pay offer pays up to $15,000 over the whole course of treatment toward the drug's out-of-pocket cost, and you pay anything above that. It cannot be used with Medicare, Medicaid, TRICARE, VA, DoD or other federal or state programs, without insurance, or when the plan does not cover Lutathera.
Lutathera is on the medication list of the Novartis Patient Assistance Foundation, which gives medicine free to people who are uninsured, have government insurance or cannot afford their medicine. You must live in the US or a US territory, be treated as an outpatient by a licensed US provider and meet income limits. Call 1-800-277-2254.
A dedicated team guides you through referral, financial help, what to expect with treatment and common questions, and works with your provider on insurance coverage.
The $15,000 co-pay cap covers the whole course of treatment, not one year. Treatment costs such as administration fees may be extra. Hours are Monday to Friday, 8 AM to 8 PM ET.
Patient Access Managers verify benefits and help with prior authorizations and appeals, and give ongoing insurance support during treatment.
Copay support for eligible commercially insured patients; annual maximum applies. Not available with Medicare, Medicaid, VA, TRICARE, or to residents of Massachusetts or California.
Free drug for US residents who are uninsured or functionally uninsured, face financial hardship, and meet financial eligibility criteria.
Patients in alternate funding programs are not eligible for free drug. Rhode Island residents get drug-cost help only, not injection costs. Mon-Fri 8 AM-8 PM ET.
People with commercial insurance that covers Xermelo may pay as little as $0 per fill. TerSera pays up to an annual maximum that resets each calendar year but does not publish the dollar amount. You must be 18 or older. People on Medicare, Medicaid, VA, DoD or any other state or federal plan, and cash-paying patients, cannot use it.
Eligible patients who show financial need and do not have insurance coverage may get Xermelo at no cost through the Patient Assistance Program. Other terms apply.
SupportSource checks your plan coverage, explains prior authorization and appeals, estimates your out-of-pocket costs and can refer eligible patients to independent assistance foundations. It also offers TerSera NurseSupport for patients prescribed Xermelo.
The copay team's number is 1-855-680-4551. The patient assistance application includes a credit check to judge financial need.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 3 drugmaker programs for Neuroendocrine Tumors medicines. We checked every one at the source on or before October 12, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Neuroendocrine Tumors, 0 charity funds on this page accept Medicare, and 1 drugmaker free medicine program names Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
Of the drugmaker programs for Neuroendocrine Tumors medicines, 3 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list () on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
